CUV 0.41% $14.64 clinuvel pharmaceuticals limited

Revenue EXPLOSION Coming?, page-67

  1. 790 Posts.
    lightbulb Created with Sketch. 1016
    I believe PigsMightFly is recommending Clinuvel Pharmaceuticals as a SCREAMING BUY. Pigs spent most of the weekend making multiple comments on Afterpay and some obscure concrete mob that he doesn't hold and recommending to Sell them. But with CUV I think he has found a winner. On the 23/06 Pigs commented that the Clinuvel STROKE program has a realistic 10% chance of SUCCESS.Now I think the chance is quite a bit higher than this for STROKE, furthermore for VITILIGO I estimate about 90% chance of Success and around 75 - 80% chance for XP and therefore SKIN CANCER treatment/prevention via DNA REPAIR. But going back to Pigs estimation of SUCCESS in the STROKE program he should buy as much CUV as he can afford right now with the knowledge he has because AIS affects about 15 MILLION people worldwide each year and for about 85% of these people it is untreatable! It is the UNTREATED 85% that CUV is targeting with their ALREADY FDA, TGA and EMA approved drug. The very SAFE drug. Approval in STROKE will instantly add about $10 BILLION to the share price in my opinion (conservative). Now remember that CUV is already undervalued compared to just about any other Biotech on the ASX despite it having superior financial fundamentals and only treating the 'proof of concept' disease EPP.

    Clinuvel is targeting MULTIPLE BLOCKBUSTER indications and is already undervalued. In your own estimation Pigs, in the least known of the indications (and therefore least likely), there is a realistic 10% chance of success. Therefore you must estimate higher chances of success for VITILIGO and XP. The company is doing great just with EPP and will grow profits for years to come and is cheap at these levels. You can BUY CUV right now Pigs and have multiple chances at hitting the jackpot with a Blockbuster indication via a drug that is already approved in the major markets worldwide. The risk to the downside is low with US sales rollout just ramping up of THE WORLD'S FIRST SYSTEMATIC PHOTOPROTECTIVE DRUG. Surely you have realised you are onto a great winner with CUV. Unless you have shorted it and are trying to escape.

    All IMO DYOR
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.64
Change
0.060(0.41%)
Mkt cap ! $731.6M
Open High Low Value Volume
$14.61 $14.99 $14.40 $618.9K 42.44K

Buyers (Bids)

No. Vol. Price($)
11 397 $14.60
 

Sellers (Offers)

Price($) Vol. No.
$14.64 373 12
View Market Depth
Last trade - 12.03pm 10/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.